1 |
Health Authority Abu Dhabi website (HAAD): available at:http://www.haad.ae/haad/ar/tabid/1214/Default.aspx.
|
2 |
Ibrahim A, Rasch V, Pukkala E, Aro AR (2011). Predictors of cervical cancer being at an advanced stage at diagnosis in Sudan. Int J Womens Hlth, 3, 385-89.
|
3 |
Lehtinen M, Paavonen J, Wheeler CM, et al (2012). Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oneal, 13, 89-99.
DOI
ScienceOn
|
4 |
Ng SW, Zaghloul S, Ali HI, Harrison G, Popkin BM (2011). The prevalence and trends of overweight, obesity and nutritionrelated non-communicable diseases in the Arabian Gulf States. Obes Rev. 12, 1-13.
|
5 |
Sahasrabuddhe VV, Parham GP, Mwanahamuntu MH, Vermund SH (2012). Cervical cancer prevention in low- and middleincome countries: feasible, affordable, essential. Cancer Prev Res (Phila). 5, 11-7.
DOI
ScienceOn
|
6 |
Zaki A, Gaber A, Ghanem E, Moemen M, Shehata G (2011). Abdominal obesity and endometrial cancer in egyptian females with postmenopausal bleeding. Nutr Cancer. 63, 1272-8.
DOI
|
7 |
Al-Kadri HM,Al-Awami SH, MadkhaliAM (2004). Assessment of risk factors of uterine cancer in Saudi patients with postmenopausal bleeding. Saudi Med J, 25, 857-61.
|
8 |
Badrinath P, Ghazal-Aswad S, Osman N, Deemas E, McIlvenny S(2004). A study of knowledge, attitude, and practice of cervical screening among female primary care physicians in the United Arab Emirates. Hlth Care Women Int. 25, 663-70.
DOI
ScienceOn
|
9 |
Crawford R, Greenberg D (2012). Improvements in survival of gynaecological cancer in the Anglia region of England: are these an effect of centralisation of care and use of multidisciplinary management? BJOG. 119, 160-5.
DOI
ScienceOn
|
10 |
El-Hazmi MA, Warsy AS (1997). Prevalence of obesity in Saudi population. Ann Saudi Med, 17, 302-6.
|
11 |
Engelen MJA, Kos HE, Willemse PHB et al (2006). Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma. Cancer, 106, 589-98.
DOI
ScienceOn
|
12 |
GAVI Alliance access at: http://www.gavialliance.org/index.aspx
|
13 |
Globocan (2008). International Agency For Research on Cancer, World Health Organization. Accessible at: http://globocan.iarc.fr/
|